Navigation Links
Your headache can stem from your body weight,,,,

Obesity may be the cause of migraines and severe headaches. In a study that had measured the influence of body mass //index on frequency, and severity of headaches, the results had shown that chronic daily headaches are more common in obese people than those with normal body weight.

The researchers had taken the physical history of the participants by telephonic interviews and had divided the number of people into five groups according to their body mass index. 67% of the respondents were female and the average age of the people who participated in the study was 43 yrs.

Obese people reported having at least one attack of severely crippling headache that makes them unable to do anything else. This frequency and severity of the headaches were less for people who are only overweight and least for people who have a normal body weight. For the people who are underweight, there were more cases of headaches accompanied by nausea.

The researchers of Albert Einstein College of Medicine did the study and had presented the results in the American Academy of Neurology 57th Annual Meeting.
'"/>




Page: 1

Related medicine news :

1. TIZANIDINE - New solution to chronic headache
2. Analgesic abuse - cause for chronic headache in children
3. Hormone replacement Therapy a headache
4. Why cluster headaches?
5. Why a headache?
6. Cervicogenic headache can be identified with a fibromyalgia test
7. Bright arctic lights to cause headaches
8. Neurostimulation Therapy to ease cluster headaches
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Your headache can stem from your body weight

(Date:11/21/2008)... NEW ROCHELLE, N.Y., Nov. 21 A pr...healthcare providers will gather in Williamsburg, ...to learn practical, clinical information on cuttin...cedures, and innovative research advances that imp...ditation, and registration information is availabl...
(Date:11/21/2008)... , NEW YORK Tobacco use is more prevalent an... Attention Deficit Hyperactivity Disorder (A.D.H.D...nd hyperactivity symptoms, those who exhibited ele...ut inattention, showed lower quit rates after 8 we...those without the A.D.H.D. symptoms. The study, n...
(Date:11/21/2008)... MINNEAPOLIS, Nov. 21 Three Minne... big prizes during a special on-ice presentation a...cel Energy Center. The winners,were participants ...est from,ClearWay Minnesota(SM) and QUITPLAN(R) S...ive $5,000 in cash, while two runners-up,will get...
(Date:11/21/2008)... LOS ANGELES, Nov. 21 In a recent...d broadening the Sales and Use Tax to include,"lu...sure to cause an increase,in animal shelter overp...ate,are joining forces and urging all pet owners ... legislature to stop this tax. , "Our compa...
Breaking Medicine News(10 mins):Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 3
...iversity of Pittsburgh have successfully treated h...y //prone to develop a human muscular dystrophy. T...e Oct. 25 edition of the journal Circulation. The ...that a gene therapy has been used in a therapeutic...
...rk Scientists now been able to map the most common...rough could change the face of future medicine. Th...team have now been able to chart genetic differenc...e from different parts of the world like Africa, ...
... avoided by patients with high cholesterol especia...t in India has developed a egg variety that does ... dependent diabetes is growing especially in India...good dietary supplement for diabetics,' said S.K. ...
... from the leaves of the evergreen plant Camellia s...a are polyphenolic compounds, known as catechins. ...% of dry // ht, including (-)-epigallocatechin ga...catechin gallate (ECG) and (-)-epicatechin (EC), w...
Other Medicine News:Health News:Gene Therapy Overcomes Heart Failure In Muscular Dystrophy 2Health News:Catechins in green tea show antiviral effect on influenza virus 2
(Date:11/20/2008)... , , , PHILADELPHIA, Nov. 20 /PRNewswir...y announced that the United States Food and Drug A...or PROMACTA(R) (eltrombopag) for the treatment of ...idiopathic) thrombocytopenic purpura (ITP) who hav... immunoglobulins or splenectomy. The approval is a...
(Date:11/20/2008)...ILLE, Calif., Nov. 20 Bi...ny will present results from the Phase 1B,clinica...metastatic breast,cancer, BZL101, at the Society ...nference in Atlanta, Georgia. The Company,s oral ...ct and will be presented as a part of the Best of ...
(Date:11/20/2008)..., Nov. 20 PAREXEL Intern...lobal biopharmaceutical services provider, today a...u to provide regulatory consulting and clinical re... office, PAREXEL now has locations throughout five...ica, which also include Argentina, Brazil, Chile, ...
(Date:11/19/2008)... , Study did not achieve statistical significan...irstCall/ -- Pharmos Corporation (Nasdaq: PARS )...l trial of its topical NanoEmulsion (NE) drug deli...hanolamine. , , The multi-center, randomize...ted the safety and efficacy of the Company,s 3% Di...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2DNA Direct Announces Availability of ColoSure 28TM 29 Colorectal Cancer Screening Test 26948 1DNA Direct Announces Availability of ColoSure 28TM 29 Colorectal Cancer Screening Test 26948 2DNA Direct Announces Availability of ColoSure 28TM 29 Colorectal Cancer Screening Test 26948 3Samarion 28SM 29 to Have Major Presence at the AHCA NACL MECF 59th Annual Convention 26 Expo 26943 1Samarion 28SM 29 to Have Major Presence at the AHCA NACL MECF 59th Annual Convention 26 Expo 26943 2Physician to Implant the CATANIA 28TM 29 Coronary Stent System With Polyzene 28R 29 F to Treat Chronic Total Occlusion During Live Case at the Paris C 8029 1Physician to Implant the CATANIA 28TM 29 Coronary Stent System With Polyzene 28R 29 F to Treat Chronic Total Occlusion During Live Case at the Paris C 8029 2Physician to Implant the CATANIA 28TM 29 Coronary Stent System With Polyzene 28R 29 F to Treat Chronic Total Occlusion During Live Case at the Paris C 8029 3Groundbreaking discovery may lead to stronger antibiotics 5163 1Groundbreaking discovery may lead to stronger antibiotics 5163 2
...rch 12, 2007 /PRNewswire-FirstCall/ --,Schering-Pl...he,Phase II trial of its novel oral thrombin recep...at the 2007 annual Scientific Sessions,of the of C...,Summit, March 24-27 in New Orleans. The Phase II ...nist in Percutaneous Coronary,Intervention (TRA-PC...
...12, 2007—InB:Biotechnologies, Inc.,("BioTech...rma,Inc. (NASDAQ: INBP), today announced strong p..., anthrax and plague made using,INBP,s novel, prop...ies were conducted by the Fraunhofer USA Center fo...arch Organization led by Dr.,Vidadi Yusibov, throu...
Other Medicine Technology:Schering-Plough Announces Presentation of Phase II Trial Results,for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual,Meeting of The American College of Cardiology/i2 Summit 2Integrated BioPharma's Proprietary Vaccine Technology Achieves,Strong Positive Results 2
...o a world of imaging applications possibilities, f...scular procedures. A veritable workhorse for all o...erall productivity of your department., System h...mpact and "room-mobile design , Broad applicatio...
ACUSON Cypress cardiovascular system PLUS is the worlds first portable, high-performance transesophageal cardiovascular imaging system a highly miniaturized, all-digital, phased array echocardiogr
...nterventional cardioangiography procedures with MR...with a cardioangiography system., Utilize you...e with our integrated suite. Because the systems c... diagnosis and follow-up in one room, one control ...
The Medical Office is a comprehensive medical billing software capable of managing the multiple provider / multiple payer requirements of healthcare billing companies.The Medical Office includes the
Medicine Products: